Indian Income Tax Appellate Tribunal classifies rights as capital assets

by | Aug 27, 2020

Following a Karnataka High Court decision, in a recent case, the Bangalore Bench of the Indian Income-tax Appellate Tribunal has held that the relinquishment of rights under an agreement are capital assets, and thus, the income arising from such relinquishment is taxable as capital gains.

The expression “capital asset” has been defined under Indian tax law to mean “property of any kind”, subject to certain exclusions. Indian courts have examined this issue and held that contractual rights such as leasehold rights, subscription rights to shares of a company, rights to obtain a sale deed, and rights to title over immovable property are capital assets.

However, in the Vodafone case, India’s Supreme Court (Justice S. Radhakrishnan in his separate judgment) explicitly stated that contractual rights in an agreement do not sound in “property”, and hence, cannot, in the absence of a statutory stipulation, be considered as capital assets. We are not sure why the Vodafone judgment was not brought to the notice of the Tribunal. The issue will remain open pending a higher court ruling.

More News

IBLJ A-List 2022-2023

We are pleased to announce that Akil Hirani, Rukshad Davar and Neerav Merchant have been included in India Business Law Journal's A-List for 2022-2023. The A-List is based on extensive research conducted by India Business Law Journal. To determine India’s...

read more

The Legal 500 Rankings 2023

Majmudar & Partners has been ranked in 13 practice areas in The Legal 500 (Legalease) Asia Pacific 2023 edition. Congratulations to the partners and the team members for their hard work and stellar performance. Ranked Practice Areas Antitrust and...

read more

Chambers and Partners Rankings 2023

Majmudar & Partners’ position as a leading Indian law firm has been affirmed by its rankings in the 2023 edition of Chambers & Partners Asia-Pacific in the practice areas of Corporate/M&A – The Elite, Dispute Resolution, Employment, Life Sciences, Real...

read more